Seasonal and perennial allergic conjunctivitis

Indication for Cromoglicic acid

Population group: Suitable for both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

For the relief and treatment of seasonal and perennial allergic conjunctivitis.

For this indication, competent medicine agencies globally authorize below treatments:

2.8-5.6 mg in 4 divided doses daily

Route of admnistration

Ophthalmic

Defined daily dose

2.8 - 5.6 mg

Dosage regimen

From 0.7 To 1.4 mg 4 time(s) per day every day

Detailed description

0.7mg or 1.4mg in each eye four times a day or as indicated by the doctor.

Active ingredient

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Read more about Cromoglicic acid

Related medicines

Summary of Product Characteristics (SPC) 2015: NALCROM Capsule
Summary of Product Characteristics (SPC) 2021: INTAL CFC-FREE Pressurised inhalation, suspension
Summary of Product Characteristics (SPC) 2019: ALLERGY RELIEF Eye drops, Solution

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner